{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:40:03Z","timestamp":1741009203915,"version":"3.38.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Healthcare claims data can support the timely surveillance of health outcomes from exposures to emerging and established environmental contaminants such as per- and polyfluoroalkyl substances (PFAS). PFAS are widely used in a variety of consumer products and industrial applications. They are detected in almost all Americans. PFAS exposure has been associated with several health outcomes including high cholesterol and thyroid disease. In 2014, PFAS were detected in five drinking water wells in New Castle City, New Castle County, Delaware. Perfluorooctane sulfonate and perfluorooctanoic acid were measured above the then Environmental Protection Agency\u2019s lifetime health advisory of 70 parts per trillion. This study uses healthcare claims data to show that healthcare plan members living in the ZIP code served by the five wells were at higher risk for type 2 diabetes, hypertension, hypertensive diseases, coronary artery disease, and hyperthyroidism based on new claims compared with healthcare plan members living elsewhere in the county. Healthcare claims data provided timely information on health outcomes not captured by traditional public health surveillance systems and at finer geographic levels.<\/jats:p>","DOI":"10.1097\/ee9.0000000000000368","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:00:38Z","timestamp":1741006838000},"page":"e368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the utility of healthcare claims data to determine potential health impacts of PFAS exposure with public drinking water"],"prefix":"10.1097","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-0327","authenticated-orcid":false,"given":"Gonza","family":"Namulanda","sequence":"first","affiliation":[{"name":"Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Condon","sequence":"additional","affiliation":[{"name":"National Center for Environmental Health\/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri Lynn","family":"Palmer","sequence":"additional","affiliation":[{"name":"Delaware Health Information Network, Dover, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ellis","sequence":"additional","affiliation":[{"name":"Freedman HealthCare, Burlington, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuen","family":"Yip","sequence":"additional","affiliation":[{"name":"Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Reh","sequence":"additional","affiliation":[{"name":"National Center for Environmental Health\/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Breysse","sequence":"additional","affiliation":[{"name":"National Center for Environmental Health\/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4]]},"reference":[{"key":"R1-20250303","first-page":"3","article-title":"Public health challenges in the United States: evolution and challenges.","volume":"61","author":"Thacker","year":"2012","journal-title":"MMWR"},{"key":"R3-20250303","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijheh.2016.09.010","article-title":"Advancing environmental health surveillance in the US through a national human biomonitoring network.","volume":"220","author":"Latshaw","year":"2017","journal-title":"Int J Hyg Environ Health"},{"key":"R4-20250303","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jbi.2018.02.012","article-title":"Electronic health record case studies to advance environmental public health tracking.","volume":"79","author":"Namulanda","year":"2018","journal-title":"J Biomed Inform"},{"key":"R5-20250303","article-title":"Drinking water health advisory for perfluorooctanoic acid (PFOA).","year":"2016"},{"key":"R6-20250303","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/PHH.0b013e3182a3e958","article-title":"Medicare claims data as public use files: a new tool for public health surveillance.","volume":"20","author":"Erdem","year":"2014","journal-title":"J Public Health Manag Pract"},{"key":"R7-20250303","first-page":"30","article-title":"Public health surveillance data: Legal, policy, ethical, regulatory, and practical issues.","volume":"61","author":"Bernstein","year":"2012","journal-title":"MMWR Suppl"},{"key":"R9-20250303","year":"2022","journal-title":"History and use of per- and polyfluoroalkyl substances (PFAS) found in the environment"},{"key":"R10-20250303","first-page":"100760","article-title":"Exposures to per-and polyfluoroalkyl substances (PFAS): potential risks to reproductive and children\u2019s health.","volume":"50","author":"Anderko","year":"2020","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"R11-20250303","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-1139(00)00251-7","article-title":"Fluoroproducts\u2014the extremophiles.","volume":"104","author":"Johns","year":"2000","journal-title":"J Fluorine Chem"},{"key":"R12-20250303","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1039\/D0EM00291G","article-title":"An overview of the uses of per- and polyfluoroalkyl substances (PFAS).","volume":"22","author":"Gluge","year":"2020","journal-title":"Environ Sci Process Impacts"},{"key":"R13-20250303","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/etc.4935","article-title":"PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding.","volume":"40","author":"De Silva","year":"2021","journal-title":"Environ Toxicol Chem"},{"key":"R14-20250303","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects.","volume":"29","author":"Sunderland","year":"2019","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"R15-20250303","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00244-008-9272-9","article-title":"Carryover of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from soil to plants.","volume":"57","author":"Stahl","year":"2009","journal-title":"Arch Environ Contam Toxicol"},{"key":"R16-20250303","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1021\/es049620g","article-title":"Fluorinated organic compounds in an eastern arctic marine food web.","volume":"38","author":"Tomy","year":"2004","journal-title":"Environ Sci Technol"},{"key":"R17-20250303","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","article-title":"Accumulation of perfluoroalkyl substances in human tissues.","volume":"59","author":"P\u00e9rez","year":"2013","journal-title":"Environ Int"},{"key":"R18-20250303","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1539-6924.2008.01017.x","article-title":"Estimating consumer exposure to PFOS and PFOA.","volume":"28","author":"Trudel","year":"2008","journal-title":"Risk Anal"},{"key":"R20-20250303","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the U.S. population: data from the national health and nutrition examination survey (NHANES) 2003\u20132004 and comparisons with NHANES 1999\u20132000.","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ Health Perspect"},{"key":"R21-20250303","article-title":"C8 probable link reports.","year":"2012"},{"key":"R22-20250303","article-title":"Review of EPA\u2019s analyses to support EPA\u2019s national primary drinking water rulemaking for PFAS.","year":"2022"},{"key":"R23-20250303","article-title":"Guidance on PFAS Exposure, Testing, and Clinical Follow-Up.","year":"2022"},{"key":"R24-20250303","article-title":"Joint subcommittee on environment innovation and public health per- and polyfluoroalkyl substances strategy team of the White House National Science and Technology Council. Per- and polyfluoroalkyl substances (PFAS) report.","year":"2023"},{"key":"R25-20250303","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.scitotenv.2018.10.245","article-title":"Per- and polyfluoroalkyl substances in source and treated drinking waters of the United States.","volume":"653","author":"Boone","year":"2019","journal-title":"Sci Total Environ"},{"key":"R26-20250303","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.envint.2017.06.007","article-title":"Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.","volume":"106","author":"Worley","year":"2017","journal-title":"Environ Int"},{"key":"R27-20250303","article-title":"2010 annual drinking water quality report.","year":"2010"},{"key":"R28-20250303","article-title":"New Castle County Delaware near New Castle Air National Air Base; per- and polyfuoroalkyl substances (PFAS) exposure assessment.","year":"2022"},{"key":"R29-20250303","article-title":"Water quality report for 2014.","year":"2015"},{"key":"R30-20250303","article-title":"2015 annual drinking water quality report.","year":"2015"},{"key":"R31-20250303","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/es035031j","article-title":"Quantitative determination of fluorotelomer sulfonates in groundwater by LC MS\/MS.","volume":"38","author":"Schultz","year":"2004","journal-title":"Environ Sci Technol"},{"key":"R32-20250303","article-title":"October 2016 Poly- and perfluoroalkyl substance groundwater sampling report.","year":"2017"},{"key":"R34-20250303","article-title":"PFAS exposure assessments.","year":"2022"},{"key":"R35-20250303","article-title":"DHIN By-Laws.","year":"2019"},{"key":"R36-20250303","article-title":"Age and gender distribution of Delaware Health Care Claims Database compared to Delaware state population.","year":"2024"},{"key":"R37-20250303","article-title":"Percentage of population without health insurance coverage by state: 2021 and 2022.","year":"2023"},{"key":"R38-20250303","article-title":"PFAS information for clinicians \u2013 2024.","year":"2024"},{"key":"R39-20250303","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R40-20250303","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/EDE.0000000000000040","article-title":"Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.","volume":"25","author":"Winquist","year":"2014","journal-title":"Epidemiology"},{"key":"R41-20250303","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinternmed.2012.3393","article-title":"Perfluorooctanoic acid and cardiovascular disease in US adults.","volume":"172","author":"Shankar","year":"2012","journal-title":"Arch Intern Med"},{"key":"R42-20250303","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12940-020-00656-0","article-title":"Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults.","volume":"19","author":"Pitter","year":"2020","journal-title":"Environ Health"},{"key":"R43-20250303","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/HYPERTENSIONAHA.121.18809","article-title":"Per- and polyfluoroalkyl substances and incident hypertension in multi-racial\/ethnic women: the study of women\u2019s health across the nation.","volume":"79","author":"Ding","year":"2022","journal-title":"Hypertension"},{"key":"R44-20250303","doi-asserted-by":"crossref","first-page":"037001","DOI":"10.1289\/EHP2619","article-title":"Plasma concentrations of perfluoroalkyl substances and risk of type 2 diabetes: a prospective investigation among U.S. women.","volume":"126","author":"Sun","year":"2018","journal-title":"Environ Health Perspect"},{"key":"R45-20250303","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.envres.2013.11.003","article-title":"Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.","volume":"128","author":"Karnes","year":"2014","journal-title":"Environ Res"},{"key":"R46-20250303","doi-asserted-by":"crossref","first-page":"108540","DOI":"10.1016\/j.envres.2019.108540","article-title":"High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohort study from Ronneby, Sweden.","volume":"176","author":"Anderson","year":"2019","journal-title":"Environ Res"},{"key":"R47-20250303","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.envres.2015.06.033","article-title":"Levels of perfluoroalkyl substances and risk of coronary heart disease: findings from a population-based longitudinal study.","volume":"142","author":"Mattsson","year":"2015","journal-title":"Environ Res"},{"key":"R48-20250303","doi-asserted-by":"crossref","first-page":"965384","DOI":"10.3389\/fendo.2022.965384","article-title":"Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk.","volume":"13","author":"Roth","year":"2022","journal-title":"Front Endocrinol"},{"key":"R49-20250303","article-title":"National defense authorization act for fiscal year 2020.","year":"2019"},{"key":"R50-20250303","article-title":"PFAS in firefighting foam (AFFF) and equipment: state-by-state regulations.","author":"Supra","year":"2023"},{"key":"R51-20250303","article-title":"House concurrent resolution No. 8.","year":"2023"},{"key":"R52-20250303","article-title":"Drinking water health advisories for GenX chemicals and PFBS.","year":"2023"},{"key":"R53-20250303","article-title":"Per- and polyfluoroalkyl substances (PFAS) final PFAS national primary drinking water regulation.","year":"2024"},{"key":"R54-20250303","article-title":"Understanding the final PFAS national primary drinking water regulation hazard index maximum contaminant level.","year":"2024"},{"key":"R55-20250303","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/acs.estlett.0c00255","article-title":"Scientific basis for managing PFAS as a chemical class.","volume":"7","author":"Kwiatkowski","year":"2020","journal-title":"Environ Sci Technol Lett"},{"key":"R56-20250303","doi-asserted-by":"crossref","first-page":"bvac172","DOI":"10.1210\/jendso\/bvac172","article-title":"Hypothyroidism prevalence in the United States: a retrospective study combining National Health and Nutrition Examination Survey and Claims Data, 2009\u20132019.","volume":"7","author":"Wyne","year":"2023","journal-title":"J Endocr Soc"},{"key":"R57-20250303","doi-asserted-by":"crossref","first-page":"117822261668588","DOI":"10.1177\/1178222616685880","article-title":"Using electronic medical record to identify patients with dyslipidemia in primary care settings: international classification of disease code matters from one region to a national database.","volume":"9","author":"Oake","year":"2017","journal-title":"Biomed Inform Insights"},{"key":"R58-20250303","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/1475-6773.13171","article-title":"Imputing race and ethnic information in administrative health data.","volume":"54","author":"Xue","year":"2019","journal-title":"Health Services Res"},{"key":"R59-20250303","article-title":"American community survey."},{"key":"R60-20250303","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41746-021-00494-5","article-title":"Harnessing electronic health records to study emerging environmental disasters: a proof of concept with perfluoroalkyl substances (PFAS).","volume":"4","author":"Boland","year":"2021","journal-title":"NPJ Digit Med"},{"key":"R61-20250303","article-title":"Data summary of the third unregulated contaminant monitoring rule.","year":"2017"},{"key":"R62-20250303","article-title":"Third unregulated contaminant monitoring rule."}],"container-title":["Environmental Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EE9.0000000000000368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:00:49Z","timestamp":1741006849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EE9.0000000000000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ee9.0000000000000368","relation":{},"ISSN":["2474-7882"],"issn-type":[{"value":"2474-7882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}